Drug shortage
Doxercalciferol Injection · Sanofi-Aventis U.S. LLC
FDA drug shortage · To Be Discontinued · updated Dec 10, 2025
Key facts
| Generic name | Doxercalciferol Injection |
|---|---|
| Company | Sanofi-Aventis U.S. LLC |
| Presentation | Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Endocrinology/Metabolism |
| Package NDCs | 58468-0126-1 |
| First posted | Dec 10, 2025 |
| Last updated | Dec 10, 2025 |
| Discontinued | Dec 10, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: